🇺🇸 LQDA — Liquidia Corporation

Salud Compra
← Volver

Precio actual

42,20 USD

Máx. histórico

91,03

85 días

Caída desde máximo

-53,64%

Rango 52 semanas

22,31 – 93,61

Variación hoy

+0,84%

Cierre anterior

41,85

Rango de hoy

41,58 – 43,37

Volumen hoy

2.182.208

Peor caída histórica

-93,87%

09/10/2018 → 04/08/2021

Recuperado en 1623 días

Volatilidad anualizada ⓘ

87,49%

Información
Nombre completo
Liquidia Corporation
Divisa
USD
Mercado
NasdaqCM
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
216
PER ⓘ
30,36 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
54,38 USD (puede no estar actualizado)
Primera cotización
26/07/2018
Precio actualizado
hace 15 horas
Sobre la empresa

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/02/2024 13,76 13,76 13,17 13,58 -0,15% 4,29% 577.400
01/02/2024 12,77 13,68 12,66 13,60 +6,42% 7,99% 740.400
31/01/2024 12,70 13,10 12,51 12,78 +1,35% 4,65% 591.200
30/01/2024 12,41 13,00 12,38 12,61 +0,80% 5,00% 871.800
29/01/2024 12,19 12,58 11,86 12,51 +2,79% 5,91% 597.900
26/01/2024 11,95 12,17 11,83 12,17 +1,67% 2,85% 803.800
25/01/2024 11,14 12,57 11,11 11,97 -0,75% 13,11% 2.366.700
24/01/2024 12,49 12,52 11,60 12,06 -1,55% 7,37% 1.922.300
23/01/2024 13,11 13,48 12,24 12,25 -5,99% 9,46% 1.970.400
22/01/2024 12,95 13,15 12,62 13,03 +1,09% 4,09% 800.500
19/01/2024 13,33 13,33 12,77 12,89 -3,37% 4,20% 1.054.200
18/01/2024 13,47 13,50 12,85 13,34 -0,67% 4,83% 1.802.100
17/01/2024 12,48 13,86 12,39 13,43 +8,48% 11,78% 1.850.200
16/01/2024 12,50 12,50 12,22 12,38 -0,48% 2,24% 694.400
12/01/2024 12,60 12,73 12,34 12,44 -0,48% 3,10% 640.200
11/01/2024 12,50 12,71 11,92 12,50 -1,03% 6,32% 1.286.700
10/01/2024 13,17 13,17 12,56 12,63 -4,10% 4,63% 803.700
09/01/2024 12,94 13,18 12,76 13,17 +2,41% 3,25% 950.000
08/01/2024 12,76 12,94 12,39 12,86 +1,58% 4,31% 914.600
05/01/2024 12,63 13,26 12,03 12,66 +3,26% 9,74% 2.129.400
04/01/2024 11,45 12,52 11,38 12,26 +8,02% 9,96% 1.654.800
03/01/2024 11,49 11,95 11,26 11,35 -1,56% 6,01% 669.900
02/01/2024 11,93 12,01 11,40 11,53 -4,16% 5,11% 1.579.300
29/12/2023 12,07 12,36 11,92 12,03 -0,33% 3,65% 788.300
28/12/2023 12,22 12,30 11,83 12,07 -0,98% 3,85% 1.062.900
27/12/2023 11,60 12,23 11,60 12,19 +4,91% 5,43% 1.188.200
26/12/2023 11,55 11,99 11,43 11,62 -1,27% 4,85% 1.312.000
22/12/2023 11,43 11,80 11,34 11,77 +4,44% 4,02% 1.703.700
21/12/2023 11,09 11,59 10,61 11,27 +5,33% 8,84% 4.371.500
20/12/2023 7,92 11,35 7,76 10,70 +35,61% 45,33% 15.647.400